Lucigen Corp - Product Pipeline Analysis, 2017 Update

  • ID: 4415774
  • Company Profile
  • 33 pages
  • GlobalData
  • Lucigen Corporation
1 of 5

FEATURED COMPANIES

  • Cellogenetics Inc
  • Empire Genomics LLC
  • Lucerna Inc
  • MORE
Summary

Lucigen Corp (Lucigen) is a medical device company that discovers, manufactures, and commercializes molecular biology product. The company’s product portfolio includes competent cells, nextgen seq, enzymes, cloning systems, PCR and amplification, cloning test kits and vectors, and protein expression. It also offers CloneSmart, BigEasy Linear, DNATerminator End Repair Kit, CloneDirect Rapid Ligation Kit, UltraClone DNA Ligation and Transformation Kits, Gel-Ready DNA Ladders, NxGen Exonuclease I, NxGen Lambda Exonuclease, NxGen Exonuclease III, NxGen RNAse Inhibitor, RNase I, T4 Polynucleotide Kinase and Pyrophosphatase, among others. The company offers next gen sequencing services such as DNA-specific sequencing services and RNA-specific sequencing services. Lucigen is headquartered in Middleton, Wisconsin, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Lucigen Corp
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Cellogenetics Inc
  • Empire Genomics LLC
  • Lucerna Inc
  • MORE
  • Lucigen Corp Company Overview
  • Lucigen Corp Company Snapshot
  • Lucigen Corp Pipeline Products and Ongoing Clinical Trials Overview
  • Lucigen Corp - Pipeline Analysis Overview
  • Lucigen Corp - Key Facts
  • Lucigen Corp - Major Products and Services
  • Lucigen Corp Pipeline Products by Development Stage
  • Lucigen Corp Pipeline Products Overview
  • ClariLight C. difficile
  • ClariLight C. difficile Product Overview
  • ClariLight C.difficile - CLIA Waiver
  • ClariLight C.difficile - CLIA Waiver Product Overview
  • ClariLight Influenza A and B
  • ClariLight Influenza A and B Product Overview
  • Diagnostic Assay - Ebola Virus (EBoV) test
  • Diagnostic Assay - Ebola Virus (EBoV) test Product Overview
  • Diagnostic Assay - Lassa virus
  • Diagnostic Assay - Lassa virus Product Overview
  • Diagnostic Assay - Marburg Virus
  • Diagnostic Assay - Marburg Virus Product Overview
  • Diagnostic Assay - Respiratory Syncytial virus (RSV) A and B
  • Diagnostic Assay - Respiratory Syncytial virus (RSV) A and B Product Overview
  • Diagnostic Test - Crimean-Congo Hemorrhagic Virus (CCHF)
  • Diagnostic Test - Crimean-Congo Hemorrhagic Virus (CCHF) Product Overview
  • Diagnostic Test - Staphylococcus aureus
  • Diagnostic Test - Staphylococcus aureus Product Overview
  • Diagnostic Test - West Nile Virus (WNV)
  • Diagnostic Test - West Nile Virus (WNV) Product Overview
  • Point-Of-Care Device - Arboviruses
  • Point-Of-Care Device - Arboviruses Product Overview
  • Point-Of-Care Device - HPV
  • Point-Of-Care Device - HPV Product Overview
  • Lucigen Corp - Key Competitors
  • Lucigen Corp - Key Employees
  • Lucigen Corp - Locations And Subsidiaries
  • Head Office
  • Recent Developments
  • Lucigen Corp, Recent Developments
  • May 05, 2015: Lucigen Expands Technological Reach with Exclusive Sigma-Aldrich Distribution Agreement
  • Oct 29, 2014: Lucigen Announces Ralph Kauten as CEO
  • May 23, 2012: Lucigen Corporation Receives $2.8m SBIR Grant From NIH For Lucigen Influenza A, B & RSV test
  • Apr 16, 2012: Lucigen Relocates To New Facility
  • Appendix
  • Methodology
  • About
  • Contact
  • Disclaimer
List of Tables
  • Lucigen Corp Pipeline Products and Ongoing Clinical Trials Overview
  • Lucigen Corp Pipeline Products by Equipment Type
  • Lucigen Corp Pipeline Products by Indication
  • Lucigen Corp, Key Facts
  • Lucigen Corp, Major Products and Services
  • Lucigen Corp Number of Pipeline Products by Development Stage
  • Lucigen Corp Pipeline Products Summary by Development Stage
  • ClariLight C. difficile - Product Status
  • ClariLight C. difficile - Product Description
  • ClariLight C.difficile - CLIA Waiver - Product Status
  • ClariLight C.difficile - CLIA Waiver - Product Description
  • ClariLight Influenza A and B - Product Status
  • ClariLight Influenza A and B - Product Description
  • Diagnostic Assay - Ebola Virus (EBoV) test - Product Status
  • Diagnostic Assay - Ebola Virus (EBoV) test - Product Description
  • Diagnostic Assay - Lassa virus - Product Status
  • Diagnostic Assay - Lassa virus - Product Description
  • Diagnostic Assay - Marburg Virus - Product Status
  • Diagnostic Assay - Marburg Virus - Product Description
  • Diagnostic Assay - Respiratory Syncytial virus (RSV) A and B - Product Status
  • Diagnostic Assay - Respiratory Syncytial virus (RSV) A and B - Product Description
  • Diagnostic Test - Crimean-Congo Hemorrhagic Virus (CCHF) - Product Status
  • Diagnostic Test - Crimean-Congo Hemorrhagic Virus (CCHF) - Product Description
  • Diagnostic Test - Staphylococcus aureus - Product Status
  • Diagnostic Test - Staphylococcus aureus - Product Description
  • Diagnostic Test - West Nile Virus (WNV) - Product Status
  • Diagnostic Test - West Nile Virus (WNV) - Product Description
  • Point-Of-Care Device - Arboviruses - Product Status
  • Point-Of-Care Device - Arboviruses - Product Description
  • Point-Of-Care Device - HPV - Product Status
  • Point-Of-Care Device - HPV - Product Description
  • Lucigen Corp, Key Employees
  • Glossary
List of Figures
  • Lucigen Corp Pipeline Products by Equipment Type
  • Lucigen Corp Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Lucerna Inc
  • H.R. Simon and Company Inc
  • Empire Genomics LLC
  • Cellogenetics Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll